ストックスクリーナーアプリを入手
17.49
0.63%
-0.11
アフターアワーズ：
17.49
Novocure Ltd (NVCR) 最新ニュース
NovoCure Ltd stock (JE00B6T5S470): Focus on Tumor Treating Fields technology as investors weigh rece - AD HOC NEWS
Frank Leonard’s Board Appointment and Insider Selling Might Change The Case For Investing In NovoCure (NVCR) - Yahoo Finance
Have Insiders Sold NovoCure Shares Recently? - simplywall.st
NovoCure Limited Adopts Amended and Restated 2024 Omnibus Incentive Plan and Reports 2026 Annual Meeting Results - Minichart
Novocure Insider Sold Shares Worth $614,635, According to a Recent SEC Filing - marketscreener.com
NovoCure Limited Elects Frank Leonard as Director, Effective June 3, 2026 - marketscreener.com
NovoCure (NASDAQ: NVCR) investors OK directors and tight 2024 incentive plan vote - Stock Titan
NovoCure (NVCR) CEO sells 34,273 shares in tax-related transaction - Stock Titan
NovoCure (NASDAQ: NVCR) director granted RSUs and options in new equity awards - Stock Titan
NovoCure (NASDAQ: NVCR) director granted RSUs and options in 2026 award - Stock Titan
NovoCure (NVCR) director receives new share and stock option awards - Stock Titan
NovoCure (NVCR) grants RSUs and stock options to director Scannell - Stock Titan
NovoCure (NASDAQ: NVCR) director granted RSUs and 16,999 stock options - Stock Titan
[Form 4] NovoCure Ltd Insider Trading Activity - Stock Titan
NovoCure (NASDAQ: NVCR) awards director new RSUs and stock options - Stock Titan
NovoCure (NASDAQ: NVCR) grants RSUs and stock options to director Vernon W. Anthony - Stock Titan
NovoCure Ltd stock (JE00B6T5S470): shares jump after double-digit move puts focus on valuation - AD HOC NEWS
Is It Too Late to Buy NovoCure Ltd (NVCR) After 11.4% Rally? GF Value Says Undervalued - GuruFocus
[144] NovoCure Ltd SEC Filing - Stock Titan
Stock Market Today, June 4: Broadcom Drags on Nasdaq at Midday - The Motley Fool
NVCR Technical Analysis & Stock Price Forecast - Intellectia AI
Tax-driven NovoCure (NASDAQ: NVCR) director share sale after RSU vesting - Stock Titan
NovoCure (NVCR) director executes 2,945-share sell-to-cover for RSU tax - Stock Titan
NovoCure (NVCR) director sells 2,945 shares to cover RSU tax withholding - Stock Titan
NovoCure (NVCR) director sells 2,945 shares in tax-related trade - Stock Titan
NovoCure (NVCR) director sells 2,945 shares to cover RSU tax - Stock Titan
NovoCure (NVCR) director Hung disposes shares in mandated tax-related sale - Stock Titan
A Look At NovoCure (NVCR) Valuation As Shares Show Mixed Recent Performance - simplywall.st
NovoCure Ltd stock (JE00B6T5S470): Nasdaq-listed cancer therapy group in focus after recent volatili - AD HOC NEWS
Piper Sandler Maintains Novocure(NVCR.US) With Buy Rating, Maintains Target Price $27 - Moomoo
NovoCure Stock Still Up Ahead of Cancer Trial Data - Bez Kabli
NovoCure Ltd stock (JE00B6T5S470): Q1 2026 growth meets one?time hit - AD HOC NEWS
NVCR Technical Analysis | Trend, Signals & Chart Patterns | NOVOCURE LTD (NASDAQ:NVCR) - ChartMill
NovoCure Earnings Call Highlights Growth, One-Time Hit - TipRanks
NovoCure LimitedOrdinary Shares (NQ: NVCR - FinancialContent
NovoCure Ltd stock (JE00B6T5S470): mixed Q4 2025 results and new Oppenheimer upgrade draw investor f - AD HOC NEWS
NovoCure (NVCR) Is Up 9.7% After Raising 2026 Revenue Outlook And Posting Stronger Q1 Sales - Sahm
NovoCure Ltd stock (JE00B6T5S470): Up 40% YTD on oncology innovation - AD HOC NEWS
A Look At NovoCure (NVCR) Valuation After Raised 2026 Revenue Guidance And Q1 Beat - simplywall.st
Soleus discloses 10.49M-share stake in NovoCure (NASDAQ: NVCR) - Stock Titan
Oncology Company Given Neutral Rating as Q1/26 Beat Sets Up Catalyst - Streetwise Reports
NovoCure Ltd (MEX:NVCRN) Stock Price & 30 Year Financial Data - GuruFocus
NovoCure Ltd (MEX:NVCRN) DCF Valuation - GuruFocus
NovoCure Ltd (MEX:NVCRN) Stock Forecast, Price Targets and Analysts Predictions - GuruFocus
NovoCure Ltd (MEX:NVCRN) Stock Earnings Transcripts - GuruFocus
Oncology Co. Tests Advanced Cancer Treatments, Reports Q1 2026 Financial Results - Streetwise Reports
MSN Money - MSN
Why NovoCure (NVCR) Is Up 33.2% After FDA Clears Optune Pax And Guidance Ticks Higher - Sahm
3 Overlooked Stocks Set to Soar in 2026 - Yahoo Finance
International Markets and NovoCure (NVCR): A Deep Dive for Investors - Yahoo Finance
Wells Fargo Maintains Novocure(NVCR.US) With Hold Rating, Raises Target Price to $17 - Moomoo
NovoCure’s Optune Pax Win And TRIDENT Data Shape Growth Outlook - Sahm
NovoCure Limited Surges As Guidance Hike Fuels NVCR Rally - timothysykes.com
Here's What Analysts Are Forecasting For NovoCure Limited (NASDAQ:NVCR) After Its First-Quarter Results - Moomoo
NovoCure Limited (NASDAQ:NVCR) Just Reported First-Quarter Earnings: Have Analysts Changed Their Mind On The Stock? - Yahoo Finance
Novocure stock falls after CMS revokes billing privileges By Investing.com - Investing.com Nigeria
NovoCure Ltd (NVCR) Shares Surge 9.3% -- What GF Score of 70 Tel - GuruFocus
NovoCure Reports Q1 2026 Results: Full Earnings Call Transcript - Sahm
1.21%
1.43%
大文字化:
|
ボリューム (24 時間):